Multiple sclerosis(MS) is a chronic immune-mediated disease characterized by inflammation in thecentral nervous system[1]. It affects more than 100,000 people in the United Kingdom and is the most common cause of disability in working-age adults[2]. For most of the patients, symptoms such ...
The AJMC® Multiple Sclerosis compendium is a comprehensive resource for clinical news and expert insights for the disabling disease that impacts the brain and spinal cord.
Our incomplete understanding of the causes and pathways involved in the onset and progression of multiple sclerosis (MS) limits our ability to effectively treat this complex neurological disease. Recent studies explore the role of immune cells at differe
Multiple sclerosis (MS) is the most common chronic inflammatory, demyelinating and neurodegenerative disease of the central nervous system in young adults. This disorder is a heterogeneous, multifactorial, immune-mediated disease that is influenced by both genetic and environmental factors. In most patien...
Multiple sclerosis in 2021: progress against progressiondoi:10.1016/S1474-4422(21)00417-8Erin S BeckDaniel S ReichElsevier BVThe Lancet Neurology
425 google scholar crossref 74. miller dhalbert psbarkhof f et al. guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis: us national ms society task force. ann neurol. 1996;396- 16 google scholar crossref 75. kappos lstädt dratzka m ...
Multiple sclerosis (MS) experts in the United Kingdom have proposed consensus guidelines for the management and treatment of pregnant women with the disease, and couples affected by MS who are planning a pregnancy. The new guidelines are expected to reduce uncertainty about treatments that are consi...
Over the past decade, several new therapies for the treatment of multiple sclerosis (MS) have been developed. Most are used in individuals with relapsing forms of MS, because these therapies mainly target the inflammatory aspects of the disease (eg, relapses, new or enhancing lesions...
Multiple sclerosis (MS) is the single biggest cause of neurological disability in young adults. It has a direct burden on both social interactions and economic costs for healthcare systems. A wide range of evidence accumulated over time indicates that there is an association between physical, cogni...
Multiple sclerosis (MS) is a common autoimmune neurological disease affecting patients’ motor, sensory, and visual performance. Stem Cell Transplantation (SCT) is a medical intervention where a patient is infused with healthy stem cells with the purpose